In a retrospective study, we analyzed the prevalence of elevated C‐reactive protein (CRP) serum levels in 148 patients with chronic myelomonocytic leukemia (CMML), their potential prognostic impact, and potential correlations with laboratory features. The gene discussed is CRP; the disease is chronic myelomonocytic leukemia.